SMLF - ETF AI Analysis
Top Page
iShares MSCI USA Small-Cap Multifactor ETF (SMLF)
SMLF, the iShares MSCI USA Small-Cap Multifactor ETF, earns a solid overall rating thanks to several strong core holdings with healthy financial performance and growth prospects. Standouts like Medpace Holdings and nVent Electric support the fund’s quality through robust earnings and positive outlooks, while weaker names such as Guardant Health, with financial instability and valuation concerns, slightly weigh on the rating. The main risk is that many top holdings show signs of high valuations or bearish/overbought technical signals, which could make the fund more sensitive to market pullbacks.
SMLF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 4.21B
- Region
- North America
- Expense Ratio
- 0.15%
- Beta
- 1.03
- Issuer
- iShares
- Inception Date
- Apr 28, 2015
- Dividend Yield
- 0.99%
- Asset Class
- Equity
- Index Tracked
- STOXX US Small Cap Equity Factor Index
SMLF Summary
SMLF is the iShares MSCI USA Small-Cap Multifactor ETF, which follows the STOXX US Small Cap Equity Factor Index. It invests mainly in smaller U.S. companies across many industries, including technology, industrials, health care, and finance. Some well-known holdings include Williams-Sonoma and EMCOR Group. Investors might consider SMLF for growth potential and diversification, since small companies can expand faster than large ones and the fund spreads money across many stocks. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.15%, which means you’ll pay about $1.50 per year for every $1,000 invested. That’s lower than the average stock ETF, especially considering it uses a multifactor strategy rather than simple passive indexing.
What would affect this ETF?
This ETF focuses on U.S. small-cap companies across sectors like technology, industrials, health care, and consumer cyclical, so it can benefit if the U.S. economy grows, business investment rises, and smaller companies outperform larger ones. However, it could be hurt by higher interest rates, economic slowdowns that hit small businesses harder, or sector-specific challenges in areas like health care and consumer spending that affect its top holdings.
SMLF Top 10 Holdings
SMLF is powered by a diverse cast of U.S. small caps, with a tilt toward industrials, tech, and health care. On the upside, Williams-Sonoma, Reliance Steel, and Medpace are all rising, giving the fund a solid backbone across consumer, materials, and clinical services. Guardant Health has been a standout growth story, adding extra spark from the health care side. On the other hand, nVent Electric, Flex, and EMCOR have been lagging lately, acting as a bit of a speed bump. Overall, the fund is domestically focused but sector-balanced, avoiding heavy concentration in any single name.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 EME | EMCOR Group | 0.83% | $34.84M | $29.75B | 1.03% | 73Outperform |
 NVT | nVent Electric | 0.66% | $27.75M | $20.39B | 8.18% | 76Outperform |
 P | Everpure | 0.59% | $25.03M | $42.31B | 15.28% | 64Neutral |
 WSM | Williams-Sonoma | 0.70% | $29.56M | $29.77B | 33.50% | 75Outperform |
 JBL | Jabil | 0.65% | $27.32M | $28.08B | 20.58% | 73Outperform |
 FLEX | Flex | 0.59% | $24.85M | $31.95B | 34.68% | 74Outperform |
 RS | Reliance Steel | 0.63% | $26.64M | $22.26B | 58.65% | 74Outperform |
 GH | Guardant Health | 0.52% | $22.02M | $23.99B | 83.54% | 61Neutral |
 MEDP | Medpace Holdings | 0.51% | $21.53M | $18.24B | 10.81% | 79Outperform |
 THC | Tenet Healthcare | 0.52% | $21.89M | $21.75B | 30.22% | 74Outperform |
SMLF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMLF, the sentiment is Positive. The current price of 85.54 is above the 20-day moving average (MA) of 84.88, below the 50-day MA of 85.57, and above the 200-day MA of 83.02, indicating a neutral trend. The MACD of 0.07 indicates Negative momentum. The RSI at 52.40 is Neutral, neither overbought nor oversold. The STOCH value of 66.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMLF.
SMLF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| SMLF | $85.54 | $94.00(9.89% Upside) | $4.21B | 0.15% | 66Neutral |
 FNDA | $36.36 | $43.01(18.30% Upside) | $8.91B | 0.25% | 68Neutral |
 FESM | $45.48 | $60.15(32.26% Upside) | $6.85B | 0.28% | 64Neutral |
 VIOO | $131.70 | $160.88(22.16% Upside) | $4.14B | 0.07% | 66Neutral |
 CALF | $58.75 | $65.66(11.76% Upside) | $3.84B | 0.59% | 65Neutral |
 XSMO | $80.33 | $101.46(26.30% Upside) | $2.81B | 0.35% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | 85.54 | 13.10 | 18.08% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 36.36 | 6.42 | 21.45% | |
| FESM | Fidelity Enhanced Small Cap ETF | 45.48 | 9.36 | 25.91% | |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 131.70 | 24.68 | 23.06% | |
| CALF | Pacer US Small Cap Cash Cows 100 ETF | 58.75 | 16.69 | 39.67% | |
| XSMO | Invesco S&P SmallCap Momentum ETF | 80.33 | 9.39 | 13.23% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.